58mOpinion
Hard-won RTI gains are at risk as privacy legislation tilts the balance against demands of democracy
Two decades after its enactment, India’s ‘sunshine law’ that encodes the Right to Information is losing its power to hold ...
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...
Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...
Korea Hydro & Nuclear Power has simultaneously demonstrated pain relief and functional improvement in a clinical trial using ...
Companies have built their security strategies around phishing simulations and educational webinars, tactics that research ...
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim efficacy data from its ongoing ...
The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...
Exclusive IDWeek 2025 coverage on HIV ART regimens, long COVID research, C difficile findings, pneumonia predictors, and more ...
TipRanks on MSN
Theriva Biologics Presents Promising Phase 2b Trial Data
Theriva Biologics ( ($TOVX) ) has provided an update. On October 20, 2025, Theriva Biologics presented expanded data from their VIRAGE Phase 2b ...
Personalized dosing strategies may be necessary for biologic therapies, especially fixed-dose options like ustekinumab, due ...
News-Medical.Net on MSN
Novel combination therapy shows promise for advanced neuroendocrine tumors
A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback